NASDAQ:TLC - Nasdaq -
Taiwan Liposome Company Ltd ADR
NASDAQ:TLC (9/28/2021, 8:00:01 PM)
7
0 (0%)
The current stock price of TLC is 7 null. In the past month the price decreased by -2.78%. In the past year, price increased by 59.45%.
Taiwan Liposome Company Ltd. is a specialty pharmaceutical company. It focuses on development and commercialization of novel nanomedicines designed to target unmet medical need in pain management, ophthalmology and oncology. The company's product pipeline consists of TLC599, TLC590, TLC399 and TLC178 which are in clinical stage. Taiwan Liposome Company Ltd. is headquartered in Taipei City, Taiwan.
Taiwan Liposome Company Ltd ADR
11TH FLOOR-1 YUANQU STREET NANGANG DISTRICT
TAIPEI CITY F5 11503
CEO: Keelung Hong
Phone: 886-2-2655-7377
The current stock price of TLC is 7 null.
The exchange symbol of Taiwan Liposome Company Ltd ADR is TLC and it is listed on the Nasdaq exchange.
TLC stock is listed on the Nasdaq exchange.
Taiwan Liposome Company Ltd ADR (TLC) has a market capitalization of 294.54M null. This makes TLC a Micro Cap stock.
Taiwan Liposome Company Ltd ADR (TLC) has a support level at 6.99 and a resistance level at 7.05. Check the full technical report for a detailed analysis of TLC support and resistance levels.
The Revenue of Taiwan Liposome Company Ltd ADR (TLC) is expected to decline by -35.08% in the next year. Check the estimates tab for more information on the TLC EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
TLC does not pay a dividend.
Taiwan Liposome Company Ltd ADR (TLC) will report earnings on 2022-01-11.
Taiwan Liposome Company Ltd ADR (TLC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.69).
ChartMill assigns a technical rating of 7 / 10 to TLC. When comparing the yearly performance of all stocks, TLC is one of the better performing stocks in the market, outperforming 84.9% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to TLC. Both the profitability and financial health of TLC have multiple concerns.
Over the last trailing twelve months TLC reported a non-GAAP Earnings per Share(EPS) of -0.69. The EPS increased by 21.61% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | -291.85% | ||
ROA | -60.71% | ||
ROE | N/A | ||
Debt/Equity | 0.67 |
ChartMill assigns a Buy % Consensus number of 80% to TLC. The Buy consensus is the average rating of analysts ratings from 2 analysts.
For the next year, analysts expect an EPS growth of 4.76% and a revenue growth -35.08% for TLC